CompletedNCT03374475
Official study titleAn Exploratory, Multicenter, Placebo-controlled, Randomized, Double-blind Study to Investigate the Antidepressant Mechanism-of-action of JNJ-42847922 in Subjects With Major Depressive Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including San DiegoDepressionMedication studyAges 18–55
- Countries
- United States, United Kingdom, Belgium, + 2 others
- Sponsor
- Janssen Research & Development, LLC
CompletedNCT02902601
Official study titleA Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Investigate the Safety, Tolerability, and Pharmacodynamics of JNJ-54175446 in Subjects With Major Depressive Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including BerlinDepressionMedication studyAges 18–64
- Countries
- Germany, Netherlands
- Sponsor
- Janssen Research & Development, LLC
CompletedNCT06280235
Official study titleA Phase II, 6-week, Multicenter, Randomized, Double Blind (Patient and Investigator) or Masked, Placebo Controlled, Dose-finding Trial to Evaluate the Efficacy, Tolerability, and Safety of Different Doses of Oral BI 1569912 as Adjunctive Therapy in MD
This study has finished and is no longer accepting participants.
Multiple locations, including TucsonDepressionMedication studyAges 18–65
- Countries
- United States, Belgium, Bulgaria, + 4 others
- Sponsor
- Boehringer Ingelheim
CompletedNCT06783361
What is this study about?This study assessed depression symptoms.
This study has finished and is no longer accepting participants.
In ErzurumDepressionDevice studyAges 18–65
- Countries
- Türkiye
- Sponsor
- Ataturk University
CompletedNCT02473289
Official study titleA Double-Blind, Placebo-Controlled, Multicenter Study of Sirukumab as Adjunctive Treatment to a Monoaminergic Antidepressant in Adults With Major Depressive Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamDepressionMedication studyAges 21–64
- Countries
- United States, Canada, United Kingdom, + 2 others
- Sponsor
- Janssen Research & Development, LLC
CompletedNCT07376369
Official study titlePrimipar Annelerde Eş Desteğinin Doğum Sonu Ebeveynlik Özgüveni ve Depresyon Düzeyleri Üzerindeki Etkisi: Kesitsel Bir Çalışma
This study has finished and is no longer accepting participants.
In IstanbulDepressionObservational studyAges 18+
- Countries
- Türkiye
- Sponsor
- Istanbul University - Cerrahpasa
CompletedNCT04199143
Official study titleCerebrovascular Reactivity to Nitrous Oxyde in Resistant Depression: the PROTOBRAIN Pilote Study
This study has finished and is no longer accepting participants.
In ToursDepressionMedication studyAges 25–50
- Countries
- France
- Sponsor
- University Hospital, Tours
CompletedNCT07318168
Official study titleRandomized Controlled Pilot Trial of a Brief Psycho-educational Intervention to Enhance Maternal Reflective Functioning in the Early Postpartum Among First-Time Mothers
This study has finished and is no longer accepting participants.
In HaifaDepressionBehavioural studyAges 18+
- Countries
- Israel
- Sponsor
- University of Haifa
CompletedNCT00576095
Official study titleHypothalamic-Pituitary-Adrenal (HPA)/ Dopamine Axis in Psychotic Depression
This study has finished and is no longer accepting participants.
In StanfordDepression, SchizophreniaObservational studyAges 18–85
- Countries
- United States
- Sponsor
- Stanford University
Active Not RecruitingNCT04684706
Official study titleA Within Study on the Effects of L-dlPFC Activation Through iTBS in Refractory Depression
This study is no longer accepting new participants.
Multiple locations, including La JollaDepressionDevice studyAges 18–70
- Countries
- United States
- Sponsor
- University of Pennsylvania
CompletedNCT03191058
Official study titleConfirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression (CREST - MST)
This study has finished and is no longer accepting participants.
Multiple locations, including San DiegoDepressionDevice studyAges 18+
- Countries
- United States, Canada
- Sponsor
- University of Texas Southwestern Medical Center
CompletedNCT05710237
Official study titleDoes Psilocybin Require Psychedelic Effects to Treat Depression? A 4-Week, Double-Blind, Proof-of-Concept Randomized Controlled Trial
This study has finished and is no longer accepting participants.
In TorontoDepressionMedication studyAges 18–65
- Countries
- Canada
- Sponsor
- Centre for Addiction and Mental Health (Hospital / academic medical center)